NF-κB activation as a pathological mechanism of septic shock and inflammation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 4, 2006, Pages

  Liu, Shu Fang ^a,c   Malik, Asrar B ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Cytokines; Nuclear factor B; Septic pathophysiology; Signal transduction

Indexed keywords

ALANTOLACTONE; AUTACOID; BENZOFURAN DERIVATIVE; CIGLITAZONE; CYTOKINE; GENE PRODUCT; I KAPPA B; I KAPPA B KINASE; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MORPHINE; NITRIC OXIDE SYNTHASE INHIBITOR; OLIGODEOXYNUCLEOTIDE; PARTHENOLIDE; PHOSPHATE; PROSTAGLANDIN DERIVATIVE; PYRROLIDINE DITHIOCARBAMATE; SCLEROGLUCAN; SN 50; TETRAHYDROISOQUINOLINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; CELL PROLIFERATION; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HYPOTENSION; IMMUNE RESPONSE; INFLAMMATION; MORTALITY; NEUTROPHIL; NONHUMAN; ORGAN INJURY; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SURVIVAL; TREATMENT OUTCOME; VASCULAR DISEASE; ANIMAL; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATION; NF-KAPPA B; SHOCK, SEPTIC;

EID: 33645116785     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00477.2005     Document Type: Review

References (269)

1. Abraham E. Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis 187, Suppl 2: S364-S369, 2003.
2. Acton RD, Dahlberg PS, Uknis ME, Klaerner HG, Fink GS, Norman JG, and Dunn DL. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors. Arch Surg 131: 1216-1221, 1996.
3. Agresti A, Lupo R, Bianchi ME, and Muller S. HMGB1 interacts differentially with members of the Rel family of transcription factors. Biochem Biophys Res Commun 302: 421-426, 2003.
4. Aizawa K, Suzuki T, Kada N, Ishihara A, Kawai-Kowase K, Matsumura T, Sasaki K, Munemasa Y, Manabe I, Kurabayashi M, Collins T, and Nagai R. Regulation of platelet-derived growth factor-A chain by Kruppel-like factor 5: new pathway of cooperative activation with nuclear factor-kappaB. J Biol Chem 279: 70-76, 2004.
5. Altavilla D, Squadrito G, Minutoli L, Deodato B, Bova A, Sardella A, Seminara P, Passaniti M, Urna G, Venuti SF, Caputi AP, and Squadrito F. Inhibition of nuclear factor-kappaB activation by IRFI 042, protects against endotoxin-induced shock. Cardiovasc Res 54: 684-693, 2002.
6. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, and Baldwin AS. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659-663, 2003.
7. Anrather J, Racchumi G, and Iadecola C. cis-acting, element-specific transcriptional activity of differentially phosphorylated nuclear factor-kappa B. J Biol Chem 280: 244-252, 2005.
8. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, and Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198, 2005.
9. Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, Renart J, Vazquez JJ, and Montiel C. Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68: 1942-1945, 2000.
10. Asamitsu K, Tetsuka T, Kanazawa S, and Okamoto T. RING finger protein AO7 supports NF-kappaB-mediated transcription by interacting with the transactivation domain of the p65 subunit. J Biol Chem 278: 26879-26887, 2003.
11. Baeuerle PA and Baichwal VR. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65: 111-137, 1997.
12. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
13. Banafsche R, Gunther L, Nefflen JU, Moutsiou S, Knolle PA, Herfarth C, and Klar E. NF-kappa B antisense oligonucleotides reduce leukocyte-endothelial interaction in hepatic ischemia-reperfusion. Transplant Proc 33: 3726-3727, 2001.
14. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, and Peterlin BM. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell 8: 327-337, 2001.
15. Beinke S, Belich MP, and Ley SC. The death domain of NF-kappa B1 p105 is essential for signal-induced p105 proteolysis. J Biol Chem 277: 24162-24168, 2002.
16. Bell S, Degitz K, Quirling M, Jilg N, Page S, and Brand K. Involvement of NF-kappaB signalling in skin physiology and disease. Cell Signal 15: 1-7, 2003.
17. Benezra M, Chevallier N, Morrison DJ, MacLachlan TK, El-Deiry WS, and Licht JD. BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit. J Biol Chem 278: 26333-263341, 2003.
18. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, and Fisher CJ Jr. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709, 2001.
19. Bettelli E, Dastrange M, and Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappaB to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 102: 5138-5143, 2005.
20. Bhat NR, Feinstein DL, Shen Q, and Bhat AN. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. J Biol Chem 277: 29584-29592, 2002.
21. Biswas G, Anandatheerthavarada HK, Zaidi M, and Avadhani NG. Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. J Cell Biol 161: 507-519, 2003.
22. Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D, Bottiger BW, Stern DM, Waldherr R, Saeger HD, Ziegler R, Bierhaus A, Martin E, and Nawroth PP. Role of NFkappaB in the mortality of sepsis. J Clin Invest 100: 972-985, 1997.
23. Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, and Ulevitch RJ. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest 102: 1645-1652, 1998.
24. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, and Karin M. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23: 4202-4210, 2004.
25. Bonizzi G and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288, 2004.
26. Brown MA and Jones WK. NF-kappaB action in sepsis: the innate immune system and the heart. Front Biosci 9: 1201-1217, 2004.
27. Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K, and Kracht M. Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem 279: 49571-49574, 2004.
28. Buss H, Dorrie A, Schmitz ML, Hoffmann E, Resch K, and Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-(kappa)B at serine 536 is mediated by multiple protein kinases including IkappaB kinase (IKK)-alpha, IKKbeta, IKKepsilon, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279: 55633-55643, 2004.
29. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, and Shoelson SE. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298, 2004.
30. Canty TG Jr, Boyle EM Jr, Farr A, Morgan EN, Verrier ED, and Pohlman TH. Oxidative stress induces NF-kappaB nuclear translocation without degradation of IkappaBalpha. Circulation 100, Suppl: II361-II364, 1999.
31. Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, Wang L, and Zhu CF. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65: 834-845, 2004.
32. Carlos TM and Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 84: 2068-20101, 1994.
33. Carlson DL, White DJ, Maass DL, Nguyen RC, Giroir B, and Horton JW. I kappa B overexpression in cardiomyocytes prevents NF-kappa B translocation and provides cardioprotection in trauma. Am J Physiol Heart Circ Physiol 284: H804-H814, 2003.
34. Carrasco D, Ryseck RP, and Bravo R. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118: 1221-1231, 1993.
35. Castrillo A, Pennington DJ, Otto F, Parker PJ, Owen MJ, and Bosca L. Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection. J Exp Med 194: 1231-1242, 2001.
36. Chantome A, Pance A, Gauthier N, Vandroux D, Chenu J, Solary E, Jeannin JF, and Reveneau S. Casein kinase II-mediated phosphorylation of NF-kappaB p65 subunit enhances inducible nitric-oxide synthase gene transcription in vivo. J Biol Chem 279: 23953-23960, 2004.
37. Chapman NR, Webster GA, Gillespie PJ, Wilson BJ, Crouch DH, and Perkins ND. A novel form of the RelA nuclear factor kappaB subunit is induced by and forms a complex with the proto-oncogene c-Myc. Biochem J 366: 459-469, 2002.
38. Chariot A, Leonardi A, Muller J, Bonif M, Brown K, and Siebenlist U. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J Biol Chem 277: 37029-37036, 2002.
39. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, and Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 17: 773-775, 2003.
40. Chen CC, Wang JK, and Lin SB. Antisense oligonucleotides targeting protein kinase C-alpha, -beta1, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism. J Immunol 161: 6206-6214, 1998.
41. Chen LF and Greene WC. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 81: 549-557, 2003.
42. Chen LF, Mu Y, and Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 21: 6539-6548, 2002.
43. Chen M, Capps C, Willerson JT, and Zoldhelyi P. E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1. Circulation 106: 2707-2713, 2002.
44. Chen Y, Vallee S, Wu J, Vu D, Sondek J, and Ghosh G. Inhibition of NF-kappaB activity by IkappaBbeta in association with kappaB-Ras. Mol Cell Biol 24: 3048-3056, 2004.
45. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, and Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416: 190-194, 2002.
46. Choi DS, Young H, McMahon T, Wang D, and Messing RO. The mouse RACK1 gene is regulated by nuclear factor-kappa B and contributes to cell survival. Mol Pharmacol 64: 1541-1548, 2003.
47. Choi M, Rolle S, Wellner M, Cardoso MC, Scheidereit C, Luft FC, and Kettritz R. Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. Blood 102: 2259-2267, 2003.
48. Cohen J. The immunopathogenesis of sepsis. Nature 420: 885-891, 2002.
49. Cohen S, Cohen S, Orian A, and Ciechanover A. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ubiquitin-ligase binding domain. J Biol Chem 276: 26769-26776, 2001.
50. Collin M, Rossi A, Cuzzocrea S, Patel NS, Di Paola R, Hadley J, Collino M, Sautebin L, and Thiemermann C. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. J Leukoc Biol 76: 961-970, 2004.
51. Collins T and Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107: 255-264, 2001.
52. Condon JC, Jeyasuria P, Faust JM, and Mendelson CR. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci USA 101: 4978-4983, 2004.
53. Corn RA, Aronica MA, Zhang F, Tong Y, Stanley SA, Kim SR, Stephenson L, Enerson B, McCarthy S, Mora A, and Boothby M. Cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response. J Immunol 171: 1816-1824, 2003.
54. Culmsee C, Culmsee C, Siewe J, Junker V, Retiounskaia M, Schwarz S, Camandola S, El-Metainy S, Behnke H, Mattson MP, and Krieglstein J. Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J Neurosci 23: 8586-8595, 2003.
55. Das S, Cho J, Lambertz I, Kelliher MA, Eliopoulos AG, Du K, and Tsichlis PN. Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner. J Biol Chem 280: 23748-23757, 2005.
56. De la Torre A, Schroeder RA, Punzalan C, and Kuo PC. Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages. J Immunol 162: 4101-4108, 1999.
57. Demarchi F, Bertoli C, Sandy P, and Schneider C. Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. J Biol Chem 78: 39583-39590, 2003.
58. Denk A, Wirth T, and Baumann B. NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev 11: 303-320, 2000.
59. Dhawan P and Richmond A. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J Biol Chem 277: 7920-7928, 2002.
60. Di Marco S, Mazroui R, Dallaire P, Chittur S, Tenenbaum SA, Radzioch D, Marette A, and Gallouzi IE. Stabilization, HuR protein, and nitric oxide release. Mol Cell Biol 25: 6533-6545, 2005.
61. D'Souza BN, Edelstein LC, Pegman PM, Smith SM, Loughran ST, Clarke A, Mehl A, Rowe M, Gelinas C, and Walls D. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. J Virol 78: 1800-1816, 2004.
62. Ea CK, Sun L, Inoue J, and Chen ZJ. TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6 TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc Natl Acad Sci USA 101: 15318-15323, 2004.
63. Egan LJ, de Lecea A, Lehrman ED, Myhre GM, Eckmann L, and Kagnoff MF. Nuclear factor-κB activation promotes restitution of wounded intestinal epithelial monolayers. Am J Physiol Cell Physiol 285: C1028-C1035, 2003.
64. Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, Myhre GM, Robine S, Karin M, and Kagnoff MF. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA 101: 2452-2457, 2004.
65. Elewaut D, Shaikh RB, Hammond KJ, De Winter H, Leishman AJ, Sidobre S, Turovskaya O, Prigozy TI, Ma L, Banks TA, Lo D, Ware CF, Cheroutre H, and Kronenberg M. NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells. J Exp Med 197: 1623-1633, 2003.
66. Espinosa L, Santos S, Ingles-Esteve J, Munoz-Canoves P, and Bigas A. p65-NFkappaB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR. J Cell Sci 115: 1295-1303, 2002.
67. Eto A, Muta T, Yamazaki S, and Takeshige K. Essential roles for NF-kappa B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I kappa B-zeta. Biochem Biophys Res Commun 301: 495-501, 2003.
68. Evans MJ, Eckert A, Lai K, Adelman SJ, and Harnish DC. Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res 89: 823-830, 2001.
69. Fagerlund R, Kinnunen L, Kohler M, Julkunen I, and Meelen K. NF-kappaB is transported into the nucleus by importin (alpha)3 and importin (alpha)4. J Biol Chem 280: 15942-15951, 2005.
70. Fan C, Li Q, Ross D, and Engelhardt JF. Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. J Biol Chem 278: 2072-2080, 2003.
71. Fan C, Li Q, Zhang Y, Liu X, Luo M, Abbott D, Zhou W, and Engelhardt JF. IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J Clin Invest 113: 746-755, 2004.
72. Fan J, Ye RD, and Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281: L1037-L1050, 2001.
73. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, and Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immun 4: 491-496, 2003.
74. Fletcher JR. Eicosanoids, critical agents in the physiological process and cellular injury. Arch Surg 128: 1192-1196, 1993.
75. Foulds S, Galustian C, Mansfield AO, and Schachter M. Transcription factor NF kappa B expression and postsurgical organ dysfunction. Ann Surg 233: 70-78, 2001.
76. Frost RA, Nystrom GJ, and Lang CH. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C(2)C(12) myoblasts via Toll-like receptor-4 and c-Jun NH2-terminal kinase pathways. Am J Physiol Cell Physiol 287: C1605-C1615, 2004.
77. Fujioka S, Schmidt C, Sclabas GM, Li Z, Pelicano H, Peng B, Yao A, Niu J, Zhang W, Evans DB, Abbruzzese JL, Huang P, and Chiao PJ. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB. J Biol Chem 279: 27549-27559, 2004.
78. Fujita F, Taniguchi Y, Kato T, Narita Y, Furuya A, Ogawa T, Sakurai H, Joh T, Itoh M, Delhase M, Karin M, and Nakanishi M. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol Cell Biol 23: 7780-7793, 2003.
79. Funakoshi-Tago M, Sonoda Y, Tanaka S, Hashimoto K, Tago K, Tominaga S, and Kasahara T. Tumor necrosis factor-induced nuclear factor kappaB activation is impaired in focal adhesion kinase-deficient fibroblasts. J Biol Chem 278: 29359-29365, 2003.
80. Furia B, Furia B, Deng L, Wu K, Baylor S, Kehn K, Li H, Donnelly R, Coleman T, and Kashanchi F. Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins. J Biol Chem 277: 4973-4980, 2002.
81. Ganster RW, Taylor BS, Shao L, and Geller DA. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB. Proc Natl Acad Sci USA 98: 8638-8643, 2001.
82. Gao Z, Chiao P, Zhang X, Zhang X, Lazar M, Seto E, Young HA, and Ye J. Coactivators and corepressors of NF-κB in I-κBα gene promoter. J Biol Chem 280: 21091-21098, 2005.
83. Ghosh S and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109: S81-S96, 2002.
84. Gil J, Garcia MA, Gomez-Puertas P, Guerra S, Rullas J, Nakano H, Alcami J, and Esteban M. TRAF family proteins link PKR with NF-kappa B activation. Mol Cell Biol 24: 4502-4512, 2004.
85. Gjertsson I, Hultgren OH, Collins LV, Pettersson S, and Tarkowski A. Impact of transcription factors AP-1 and NF-kappaB on the outcome of experimental Staphylococcus aureus arthritis and sepsis. Microbes Infect 3: 527-534, 2001.
86. Graciano AL, Bryant DD, White DJ, Horton J, Bowles NE, and Giroir BP. Targeted disruption of ICAM-1, P-selectin genes improves cardiac function and survival in TNF-α transgenic mice. Am J Physiol Heart Circ Physiol 280: H1464-H1471, 2001.
87. Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, and Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185: 1089-1099, 1997.
88. Gustin JA, Maehama T, Dixon JE, and Donner DB. The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity. J Biol Chem 276: 27740-27744, 2001.
89. Gutierrez H, Hale VA, Dolcet X, and Davies A. NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development 132: 1713-1726, 2005.
90. Hall AJ, Vos HL, and Bertina RM. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation. J Biol Chem 274: 376-383, 1999.
91. Haller D, Russo MP, Sartor RB, and Jobin C. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem 277: 38168-38178, 2002.
92. Han SJ, Ko HM, Choi JH, Seo KH, Lee HS, Choi EK, Choi IW, Lee HK, and Im SY. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). J Biol Chem 277: 44715-44721, 2002.
93. Haudek SB, Spencer E, Bryant DD, White DJ, Maass D, Horton JW, Chen ZJ, and Giroir BP. Overexpression of cardiac I-κBα prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol 280: H962-H968, 2001.
94. Hayden MS and Ghosh S. Signaling to NF-kappaB. Genes Dev 18: 2195-2224, 2004.
95. Heyninck K, Wullaert A, and Beyaert R. Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. Biochem Pharmacol 66: 1409-1415, 2003.
96. Ho RC, Hirshman MF, Li Y, Cai D, Farmer JR, Aschenbach WG, Witczak CA, Shoelson SE, and Goodyear LJ. Regulation of IκB kinase and NF-κB in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol 289: C794-C801, 2005.
97. Hoffmann A, Levchenko A, Scott ML, and Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245, 2002.
98. Hollenberg SM, Broussard M, Osman J, and Parrillo JE. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 86: 774-778, 2000.
99. Hong JW, Allen CE, and Wu LC. Inhibition of NF-kappaB by ZAS3, a zinc-finger protein that also binds to the kappaB motif. Proc Natl Acad Sci USA 100: 12301-12306, 2003.
100. Hou B, Eren M, Painter CA, Covington JW, Dixon JD, Schoenhard JA, and Vaughan DE. Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. J Biol Chem 279: 18127-18136, 2004.
101. Hou S, Guan H, and Ricciardi RP. Phosphorylation of serine 337 of NF-kappaB p50 is critical for DNA binding. J Biol Chem 278: 45994-45998, 2003.
102. Howard M, Muchamuel T, Andrade S, and Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177: 1205-1208, 1993.
103. Huang Q, Yang J, Lin Y, Walker C, Cheng J, Liu ZG, and Su B. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Immun 5: 98-103, 2004.
104. Huang WC, Chen JJ, and Chen CC. c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. J Biol Chem 278: 9944-9952, 2003.
105. Hunter RB and Kandarian SC. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 114: 1504-1511, 2004.
106. Ikezoe T, Yang Y, Heber D, Taguchi H, and Koeffler HP. PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock. Mol Pharmacol 64: 1521-1529, 2003.
107. Imose M, Nagaki M, Kimura K, Takai S, Imao M, Naiki T, Osawa Y, Asano T, Hayashi H, and Moriwaki H. Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB. Hepatology 40: 1160-1169, 2004.
108. Inoue J, Kerr LD, Kakizuka A, and Verma IM. I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell 68: 1109-1120, 1992.
109. Ishitani T, Takaesu G, Ninomiya-Tsuji J, Shibuya H, Gaynor RB, and Matsumoto K. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J 22: 6277-6288, 2003.
110. Ito T, Morimatsu M, Oonuma T, Shiina T, Kitamura H, and Syuto B. Transcriptional regulation of the MAIL gene in LPS-stimulated RAW264 mouse macrophages. Gene 342:137-143, 2004.
111. Jacobs ER, Soulsby ME, Bone RC, Wilson FJ Jr, and Hiller FC. Ibuprofen in canine endotoxin shock. J Clin Invest 70: 536-541, 1982.
112. Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, and Cohen RA. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. J Biol Chem 279: 1323-1329, 2004.
113. Jiang X, Takahashi N, Matsui N, Tetsuka T, and Okamoto T. The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J Biol Chem 278: 919-926, 2003.
114. Jones WK, Brown M, Wilhide M, He S, and Ren X. NF-kappaB in cardiovascular disease: diverse and specific effects of a "general" transcription factor? Cardiovasc Toxicol 5: 183-202, 2005.
115. Joshi AR, Chung CS, Song GY, Lomas J, Priester RA, and Ayala A. NF-kappaB activation has tissue-specific effects on immune cell apoptosis during polymicrobial sepsis. Shock 18: 380-386, 2002.
116. Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, and Miyamoto Y. Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J Biol Chem 277: 24049-24056, 2002.
117. Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L, and Chen ZJ. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell 15: 535-548, 2004.
118. Kang YJ, Seo SJ, Yun-Choi HS, Lee DH, Kim YM, and Chang KC. A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock. J Pharmacol Exp Ther 301: 561-567, 2002.
119. Karin M and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kappa B activity. Annu Rev Immunol 18: 621-663, 2000.
120. Kelly A, Vereker E, Nolan Y, Brady M, Barry C, Loscher CE, Mills KH, and Lynch MA. Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus. J Biol Chem 278: 19453-19462, 2003.
121. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, and Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immun 5: 104-112, 2004.
122. Kilbourn RG, Szabo C, and Traber DL. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7: 235-246, 1997.
123. Kim T, Yoon J, Cho H, Lee WB, Kim J, Song YH, Kim SN, Yoon JH, Kim-Ha J, and Kim YJ. Downregulation of lipopolysaccharide response in Drosophila by negative crosstalk between the AP1 and NF-kappaB signaling modules. Nat Immun 6: 211-218, 2005.
124. Kitamura H, Kanehira K, Okita K, Morimatsu M, and Saito M. MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production. FEBS Lett 485: 53-56, 2000.
125. 2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts. J Biol Chem 278: 8286-8293, 2003.
126. Kristof AS, Goldberg P, Laubach V, and Hussain SN. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 158: 1883-1889, 1998.
127. Kurtovic J and Segal I. Recent advances in biological therapy for inflammatory bowel disease. Trop Gastroenterol 25: 9-14, 2004.
128. Laderach D, Compagno D, Danos O, Vainchenker W, and Galy A. RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J Immunol 171: 1750-1757, 2003.
129. Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, Byers S, and Gaynor RB. Regulation of beta-catenin function by the IkappaB kinases. J Biol Chem 276: 42276-42286, 2001.
130. Lamhamedi-Cherradi SE, Zheng S, Hilliard BA, Xu L, Sun J, Alsheadat S, Liou HC, and Chen YH. Transcriptional regulation of type I diabetes by NF-kappa B. J Immunol 171: 4886-4892, 2003.
131. Lauzurica P, Martinez-Martinez S, Marazuela M, Gomez del Arco P, Martinez C, Sanchez-Madrid F, and Redondo JM. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur J Immunol 29: 1890-1900, 1999.
132. Lavon I, Goldberg I, Amit S, Landsman L, Jung S, Tsuberi BZ, Barshack I, Kopolovic J, Galun E, Bujard H, and Ben-Neriah Y. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat Med 6: 573-577, 2000.
133. Lawrence T, Bebien M, Liu GY, Nizet V, and Karin M. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434: 1138-1143, 2005.
134. Lawrence T, Gilroy DW, Colville-Nash PR, and Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 7: 1291-1297, 2001.
135. Lebron F, Vassallo R, Puri V, and Limper AH. Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation. J Biol Chem 278: 25001-25008, 2003.
136. Lee J, Kim YS, Choi DH, Bang MS, Han TR, Joh TH, and Kim SY. Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J Biol Chem 279: 53725-53735, 2004.
137. LeviMand Van Der Poll T. Coagulation in sepsis: all bugs bite equally. Crit Care 8: 99-100, 2004.
138. Li P, Allen H, Banerjee S, and Seshadri T. Characterization of mice deficient in interleukin-1 beta converting enzyme. J Cell Biochem 64: 27-32, 1997.
139. Li Q and Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734, 2002.
140. Liaudet L, Soriano FG, and Szabo C. Biology of nitric oxide signaling. Crit Care Med 28, Suppl: N37-N52, 2000.
141. Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, and Kuo ML. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J Biol Chem 279: 24015-24023, 2004.
142. Liu A, Hoffman PW, Lu W, and Bai G. NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation. J Biol Chem 279: 17449-17458, 2004.
143. Liu B, Yang R, Wong KA, Getman C, Stein N, Teitell MA, Cheng G, Wu H, and Shuai K. Negative regulation of NF-kappaB signaling by PIAS1. Mol Cell Biol 25: 1113-1123, 2005.
144. Liu SF, Ye XB, and Malik AB. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression proinflammatory genes. Circulation 100: 1330-1337, 1999.
145. Liu SF, Ye XB, and Malik AB. Pyrrolidine dithiocarbamate prevents I-κB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 55: 658-667, 1999.
146. Liu SF, Ye XB, and Malik AB. In vivo inhibition of NF-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 159: 3976-3983, 1997.
147. Li-Weber M, Giaisi M, Baumann S, Palfi K, and Krammer PH. NF-kappa B synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur J Immunol 34: 1111-1118, 2004.
148. Lopez-Franco O, Suzuki Y, Sanjuan G, Blanco J, Hernandez-Vargas P, Yo Y, Kopp J, Egido J, and Gomez-Guerrero C. Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol 161: 1497-1505, 2002.
149. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, and Said HM. TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am J Physiol Gastrointest Liver Physiol 286: G367-G376, 2004.
150. Ma XY, Wang H, Ding B, Zhong H, Ghosh S, and Lengyel P. The interferon- inducible p202a protein modulates NF-kappaB activity by inhibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers while enhancing the binding of p50 homodimers. J Biol Chem 278: 23008-23019, 2003.
151. Mackenzie GG, Mackenzie GG, Zago MP, Keen CL, and Oteiza PI. Low intracellular zinc impairs the translocation of activated NF-kappa B to the nuclei in human neuroblastoma IMR-32 cells. J Biol Chem 277: 34610-34617, 2002.
152. Mahabeleshwar GH and Kundu GC. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of Ikappa-Balpha following hypoxia/reoxygenation. J Biol Chem 278: 52598-52612, 2003.
153. Maiuri MC, De Stefano D, Mele G, Fecarotta S, Greco L, Troncone R, and Carnuccio R. Nuclear factor kappa B is activated in small intestinal mucosa of celiac patients. J Mol Med 81: 373-379, 2003.
154. Marchetti L, Klein M, Schlett K, Pfizenmaier K, and Eisel UL. TNF mediated neuroprotection against glutamate induced excitotoxicity is enhanced by NMDA receptor activation: Essential role of a TNF receptor 2 mediated, PI3 kinase dependent NF-kB pathway. J Biol Chem 279: 32869-32881. 2004.
155. Marienfeld R, May MJ, Berberich I, Serfling E, Ghosh S, and Neumann M. RelB forms transcriptionally inactive complexes with RelA/p65. J Biol Chem 278: 19852-19860, 2003.
156. Martin GS, Mannino DM, Eaton S, and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554, 2003.
157. Mattson MP and Cammandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107: 247-254, 2001.
158. McCarthy JV, Ni J, and Dixit VM. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem 273: 16968-16975, 1998.
159. Medvedev AE, Kopydlowski KM, and Vogel SN. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 164: 5564-5574, 2000.
160. Meffert MK and Baltimore D. Physiological functions for brain NF-kappaB. Trends Neurosci 28: 37-43, 2005.
161. Meylan E, Martinon F, Thome M, Gschwendt M, and Tschopp J. RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis. EMBO Rep 3: 1201-1208, 2002.
162. Micheau O, Lens S, Gaide O, Alevizopoulos K, and Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21: 5299-5305, 2001.
163. Miller DL, Welty-Wolf K, Carraway MS, Ezban M, Ghio A, Suliman H, and Piantadosi CA. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol 26: 650-658, 2002.
164. Misra A, Haudek SB, Knuefermann P, Vallejo JG, Chen ZJ, Michael LH, Sivasubramanian N, Olson EN, Entman ML, and Mann DL. Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 108: 3075-3058, 2003.
165. Mistry P, Deacon K, Mistry S, Blank J, and Patel R. NF-kappaB promotes survival during mitotic cell cycle arrest. J Biol Chem 279: 1482-1489, 2004.
166. Mizgerd JP, Peschon JJ, and Doerschuk CM. Roles of tumor necrosis factor receptor signaling during murine Escherichia coli pneumonia. Am J Respir Cell Mol Biol 22: 85-91, 2000.
167. Miyake K. Endotoxin recognition molecules, Toll-like receptor 4-MD-2. Semin Immunol 16: 11-16, 2004.
168. Monteleone G, Mann J, Monteleone I, Vavassori P, Bremner R, Fantini M, Del Vecchio Blanco G, Tersigni R, Alessandroni L, Mann D, Pallone F, and MacDonald TT. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation. J Biol Chem 279: 3925-3932, 2004.
169. Moorthy AK and Ghosh G. Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B. J Biol Chem 278: 556-566, 2003.
170. Murthy KG, Deb A, Goonesekera S, Szabo C, and Salzman AL. Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro. J Biol Chem 279: 5667-5675, 2004.
171. Natoli G, Saccani S, Bosisio D, and Marazzi I. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immun 6: 439-445, 2005.
172. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, Unitt JF, Sullivan E, Grimley R, Benson N, Broomhead D, Kell DB, and White MR. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 306: 704-708, 2004.
173. Nemoto S, DiDonato JA, and Lin A. Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NFkappaB-inducing kinase. Mol Cell Biol 18: 7336-7343, 1998.
174. Nishi T, Shimizu N, Hiramoto M, Sato I, Yamaguchi Y, Hasegawa M, Aizawa S, Tanaka H, Kataoka K, Watanabe H, and Handa H. Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J Biol Chem 277: 44548-44556, 2002.
175. Norlin S, Ahlgren U, and Edlund H. Nuclear factor-(kappa)B activity in beta-cells is required for glucose-stimulated insulin secretion. Diabetes 54: 125-132, 2005.
176. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, and Koistinaho J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35: 987-991, 2004.
177. Nys M, Deby-Dupont G, Habraken Y, Legrand-Poels S, Kohnen S, Ledoux D, Canivet JL, Damas P, and Lamy M. Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: role of reactive oxygen/nitrogen species and cytokines. Nitric Oxide 9: 33-43, 2003.
178. Oakley F, Mann J, Ruddell RG, Pickford J, Weinmaster G, and Mann DA. Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. J Biol Chem 278: 24359-24370, 2003.
179. Oeth PA, Parry GC, Kunsch C, Nantermet P, Rosen CA, and Mackman N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol 14: 3772-3781, 1999.
180. Ogushi I, Iimuro Y, Seki E, Son G, Hirano T, Hada T, Tsutsui H, Nakanishi K, Morishita R, Kaneda Y, and Fujimoto J. Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology 38: 335-344, 2003.
181. Ohmori K, Takeda S, Miyoshi S, Minami M, Nakane S, Ohta M, Sawa Y, and Matsuda H. Attenuation of lung injury in allograft rejection using NF-kappaB decoy transfection-novel strategy for use in lung transplantation. Eur J Cardiothorac Surg 27: 23-27, 2005.
182. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, and de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18: 4446-4454, 1999.
183. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866, 1999.
184. Panta GR, Kaur S, Cavin LG, Cortes ML, Mercurio F, Lothstein L, Sweatman TW, Israel M, and Arsura M. ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage. Mol Cell Biol 24: 1823-1835, 2004.
185. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S, Nguyen DU, Pham CG, Nelsbach AH, Melis T, Smaele ED, Tang WJ, D'Adamio L, and Franzoso G. Gadd45 beta mediates the NFkappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 6: 146-153, 2004.
186. Papin S, Cazeneuve C, Duquesnoy P, Jeru I, Sahali D, and Amselem S. The tumor necrosis factor alpha-dependent activation of the human Mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C/EBP beta and NF kappaB p65. J Biol Chem 278: 48839-48847, 2003.
187. Park MY, Jang HD, Lee SY, Lee KJ, and Kim E. Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB. J Biol Chem 279: 2544-2549, 2004.
188. Parratt JR. Nitric oxide: a key mediator in sepsis and endotoxemia? J Physiol Pharmacol 48: 493-506, 1997.
189. Peters RT, Liao SM, and Maniatis T. IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol Cell 5: 513-522, 2000.
190. Pineda-Molina E and Lamas S. S-glutathionylation of NF-kappa B subunit p50. Methods Enzymol 359: 268-279, 2002.
191. Pocock J, Gomez-Guerrero C, Harendza S, Ayoub M, Hernandez-Vargas P, Zahner G, Stahl RA, and Thaiss F. Differential activation of NF-kappa B, AP-1, and C/EBP in endotoxin-tolerant rats: mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression. J Immunol 170: 6280-6291, 2003.
192. Pomerantz JL and Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18: 6694-6704, 1999.
193. Pomerantz JL and Baltimore D. Two pathways to NF-kappaB. Mol Cell 10: 693-695, 2002.
194. Prajapati S, Verma U, Yamamoto Y, Kwak YT, and Gaynor RB. Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity. J Biol Chem 279: 1739-1746, 2004.
195. Pritts TA, Moon MR, Wang Q, Hungness ES, Salzman AL, Fischer JE, and Hasselgren PO. Activation of NF-kappaB varies in different regions of the gastrointestinal tract during endotoxemia. Shock 14: 118-122, 2000.
196. Puneet P, Moochhala S, and Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 288: L3-L15, 2005.
197. Purcell NH and Molkentin JD. Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? Circulation 108: 638-640, 2003.
198. Qing G, Qu Z, and Xiao G. Regulation of NF-kappa B2 p100 processing by its cis-acting domain. J Biol Chem 280: 18-27, 2005.
199. Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Harken AH, and Meng X. ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. Am J Physiol Regul Integr Comp Physiol 283: R477-R486, 2002.
200. Rahman A, Anwar KN, True AL, and Malik AB. Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol 162: 5466-5476, 1999.
201. Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, Wouters EF, van der Vliet A, and Janssen-Heininger YM. Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci USA 101: 8945-8950, 2004.
202. Riedemann NC, Guo RF, and Ward PA. The enigma of sepsis. J Clin Invest 112: 460-467, 2003.
203. Rosenberger CM and Finlay BB. Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat Rev Mol Cell Biol 4: 385-396, 2003.
204. Ross SD, Kron IL, Gangemi JJ, Shockey KS, Stoler M, Kern JA, Tribble CG, and Laubach VE. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am J Physiol Lung Cell Mol Physiol 279: L528-L536, 2000.
205. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S, and Lu KP. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12: 1413-1426, 2003.
206. Saccani S, Marazzi I, Beg AA, and Natoli G. Degradation of promoter-bound p65RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med 200: 107-113, 2004.
207. Sarman G, Shappell SB, Mason EO Jr, Smith CW, and Kaplan SL. Susceptibility to local and systemic bacterial infections in intercellular adhesion molecule 1-deficient transgenic mice. J Infect Dis 172: 1001-1006, 1995.
208. Savkovic SD, Koutsouris A, and Hecht G. PKCζ participates in activation of inflammatory response induced by enteropathogenic E. coli. Am J Physiol Cell Physiol 285: C512-C521, 2003.
209. Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, and Wiener-Kronish JP. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 159: 2858-2866, 1997.
210. Schmidt C, Peng B, Li Z, Sclabas GM, Fujioka S, Niu J, Schmidt-Supprian M, Evans DB, Abbruzzese JL, and Chiao PJ. Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation. Mol Cell 12: 1287-1300, 2003.
211. Schmidt-Supprian M, Courtois G, Tian J, Coyle AJ, Israel A, Rajewsky K, and Pasparakis M. Mature T cells depend on signaling through the IKK complex. Immunity 19: 377-389, 2003.
212. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, and Abraham E. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 24: 1285-1292, 1996.
213. Sen R and Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716, 1986.
214. Sepulveda MA, Emelyanov AV, and Birshtein BK. NF-kappa B and Oct-2 synergize to activate the human 3′ Igh hs4 enhancer in B cells. J Immunol 172: 1054-1064, 2004.
215. Serio KJ, Reddy KV, and Bigby TD. Lipopolysaccharide induces 5-lipoxygenase activating protein gene expression in THP-1 cells via a NF-κB and C/EBP-mediated mechanism. Am J Physiol Cell Physiol 288: C1125-C1133, 2005.
216. Sha WC, Liou HC, Tuomanen EI, and Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80: 321-330, 1995.
217. Shames BD, Meldrum DR, Selzman CH, Pulido EJ, Cain BS, Banerjee A, Harken AH, and Meng X. Increased levels of myocardial IκB-α protein promote tolerance to endotoxin. Am J Physiol Heart Circ Physiol 275: H1084-H1091, 1998.
218. Shanley TP, Warner RL, and Ward PA. The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1: 40-45, 1995.
219. Sheehan M, Wong H, Hake PW, Malhotra V, O'Connor M, and Zingarelli B. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol 61: 953-963, 2002.
220. Sheehan M, Wong H, Hake PW, and Zingarelli B. Protective effects of isohelenin, an inhibitor of nuclear factor kappaB, in endotoxic shock in rats. J Endotoxin Res 8: 99-107, 2002.
221. Sheehan M, Wong H, Hake PW, and Zingarelli B. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit Care Med 31: 2263-2270, 2003.
222. Shen CH and Stavnezer J. Interaction of Stat6 and NF-κB: direct association and synergistic activation of interleukin-4-induced transcription. Mol Cell Biol 18: 3395-3404, 1998.
223. Shenkar R, Yum HK, Arcaroli J, Kupfner J, and Abraham E. Interactions between CBP, NF-κB, and CREB in the lungs after hemorrhage and endotoxemia. Am J Physiol Lung Cell Mol Physiol 281: L418-L426, 2001.
224. Shishodia S and Aggarwal BB. Nuclear factor-kappaB: a friend or a foe in cancer? Biochem Pharmacol 68: 1071-1080, 2004.
225. Siebenlist U, Brown K, and Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 5: 435-445, 2005.
226. Siebenlist U, Franzoso G, and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10: 405-455, 1994.
227. Silverman N, Zhou R, Erlich RL, Hunter M, Bernstein E, Schneider D, and Maniatis T. Immune activation of NF-kappaB and JNK requires Drosophila TAK1. J Biol Chem 278: 48928-48934, 2003.
228. Snyder JG, Prewitt R, Campsen J, and Britt LD. PDTC and Mg132, inhibitors of NF-kappaB, block endotoxin induced vasodilation of isolated rat skeletal muscle arterioles. Shock 17: 304-307, 2002.
229. Sohn RH, Deming CB, Johns DC, Champion NC, Bian C, Gardner K, and Rade JJ. Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood 105: 3910-3917, 2005.
230. Song HY, Régnier CH, Kirschning CJ, Goeddel DV, and Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 94: 9792-9796, 1997.
231. Sosic D, Richardson JA, Yu K, Ornitz DM, and Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 112: 169-180, 2003.
232. Strassheim D, Asehnoune K, Park JS, Kim JY, He Q, Richter D, Kuhn K, Mitra S, and Abraham E. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J Immunol 172: 5727-5733, 2004.
233. Su TT, Guo B, Kawakami Y, Sommer K, Chae K, Humphries LA, Kato RM, Kang S, Patrone L, Wall R, Teitell M, Leitges M, Kawakami T, and Rawlings DJ. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immun 3: 780-786, 2002.
234. Tak PP and Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7-11, 2001.
235. Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, and Aggarwal BB. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 278: 24233-24241, 2003.
236. Takase O, Hirahashi J, Takayanagi A, Chikaraishi A, Marumo T, Ozawa Y, Hayashi M, Shimizu N, and Saruta T. Gene transfer of truncated IkappaBalpha prevents tubulointerstitial injury. Kidney Int 63: 501-513, 2003.
237. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, and Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169: 10-14, 2002.
238. Tamada S, Nakatani T, Asai T, Tashiro K, Komiya T, Sumi T, Okamura M, Kim S, Iwao H, Kishimoto T, Yamanaka S, and Miura K. Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy. Kidney Int 63: 306-314, 2003.
239. Thanos D and Maniatis T. NF-kappa B: a lesson in family values. Cell 80: 529-532, 1995.
240. Ueno T, Sawa Y, Kitagawa-Sakakida S, Nishimura M, Morishita R, Kaneda Y, Kohmura E, Yoshimine T, and Matsuda H. Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest. J Thorac Cardiovasc Surg 122: 720-727, 2001.
241. Ulevitch RJ. Therapeutics targeting the innate immune system. Nat Rev Immunol 4: 512-520, 2004.
242. Vasudevan KM, Gurumurthy S, and Rangnekar VM. Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol 24: 1007-1021, 2004.
243. Verma UN, Yamamoto Y, Prajapati S, and Gaynor RB. Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression. J Biol Chem 279: 3509-3515, 2004.
244. Vivarelli MS, McDonald D, Miller M, Cusson N, Kelliher M, and Geha RS. RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation. J Exp Med 200: 399-404, 2004.
245. Vos IH, Govers R, Grone HJ, Kleij L, Schurink M, De Weger RA, Goldschmeding R, and Rabelink TJ. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 14: 815-822, 2000.
246. Wang J, Barke RA, Charboneau R, and Roy S. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 174: 426-434, 2005.
247. Wang Q, Fang CH, and Hasselgren PO. Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281: R1013-R1023, 2001.
248. Waris G, Livolsi A, Imbert V, Peyron JF, and Siddiqui A. Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J Biol Chem 278: 40778-40787, 2003.
249. Watabe M, Hishikawa K, Takayanagi A, Shimizu N, and Nakaki T. Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells. J Biol Chem 279: 6017-6026, 2004.
250. Williams DL, Ha T, Li C, Kalbfleisch JH, Laffan JJ, and Ferguson DA. Inhibiting early activation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1,3)-beta-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 126: 54-65, 1999.
251. Woods M, Wood EG, Bardswell SC, Bishop-Bailey D, Barker S, Wort SJ, Mitchell JA, and Warner TD. Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Mol Pharmacol 64: 923-931, 2003.
252. Wright JG and Christman JW. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med 2: 211-219, 2003.
253. Wu M, Xu LG, Zhai Z, and Shu HB. SINK is a p65-interacting negative regulator of NF-kappaB-dependent transcription. J Biol Chem 278: 27072-27079, 2003.
254. Xia C, Watton S, Nagl S, Samuel J, Lovegrove J, Cheshire J, and Woo P. Novel sites in the p65 subunit of NF-kappaB interact with TFIIB to facilitate NF-kappaB induced transcription. FEBS Lett 561: 217-222, 2004.
255. Xu H, Gonzalo JA, St Pierre Y, Williams IR, Kupper TS, Cotran RS, Springer TA, and Gutierrez-Ramos JC. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med 180: 95-109, 1994.
256. Xu MQ, Suo YP, Gong JP, Zhang MM, and Yan LN. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol 10: 2361-2368, 2004.
257. Yamamoto M, Takeda K, and Akira S. TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol 40: 861-868, 2004.
258. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, and Gaynor RB. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423: 655-659, 2003.
259. Yamazaki S, Muta T, and Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J Biol Chem 276: 27657-27662, 2001.
260. Yang J, Fan GH, Wadzinski BE, Sakurai H, and Richmond A. Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J Biol Chem 276: 47828-47833, 2001.
261. Yang L, Ross K, and Qwarnstrom EE. RelA control of I-κBα phosphorylation: a positive feedback loop for high affinity NF-kappaB complexes. J Biol Chem 278: 30881-30888, 2003.
262. Ye X and Liu SF. Lipopolysaccharide down-regulates promoter selective transcription factor 1 binding activity by promoting Sp1 protein dephosphorylation and degradation. J Biol Chem 277: 31863-31870, 2002.
263. Yeh PY, Yeh KH, Chuang SE, Song YC, and Cheng AL. Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation. J Biol Chem 279: 26143-26148, 2004.
264. Yokoseki O, Suzuki J, Kitabayashi H, Watanabe N, Wada Y, Aoki M, Morishita R, Kaneda Y, Ogihara T, Futamatsu H, Kobayashi Y, and Isobe M. Cis element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats. Circ Res 89: 899-906, 2001.
265. Yuan Liu X, Robinson D, Veach RA, Liu D, Timmons S, Collins RD, and Hawiger J. Peptide-directed suppression of a pro-inflammatory cytokine response. J Biol Chem 275: 16774-16778, 2000.
266. Zhang XY, Shimura S, Masuda T, Saitoh H, and Shirato K. Antisense oligonucleotides to NF-kappaB improve survival in bleomycin-induced pneumopathy of the mouse. Am J Respir Crit Care Med 162: 1561-1568, 2000.
267. Zhong H, May MJ, Jimi E, and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-936, 2002.
268. Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denenberg A, and Cook JA. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12, 14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 171: 6827-6837, 2003.
269. Zou L, Attuwaybi B, and Kone BC. Effects of NF-κB inhibition on mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 284: G713-G721, 2003.